Annual Report 2025

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2025 152 The United Laboratories International Holdings Limited Annual Report 2025 42. INFORMATION ABOUT THE STATEMENT OF FINANCIAL POSITION OF THE COMPANY (a) Statement of financial position of the Company 2025 2024 RMB’000 RMB’000 Non-current assets Interests in subsidiaries – 2,552,000 Right-of-use assets 1,332 2,173 Property, plant and equipment 219 290 1,551 2,554,463 Current assets Other receivables and prepayments 14,019 1,765 Amounts due from subsidiaries 2,470,134 106,847 Cash and cash equivalents 4,385,044 1,760,357 6,869,197 1,868,969 Current liabilities Other payables and accrued charges 5,848 11,646 Amounts due to subsidiaries 239,604 196,199 Borrowing – due within one year 500,000 270,000 Lease liabilities 520 1,394 Tax payables 1,126 3,639 747,098 482,878 Net current assets 6,122,099 1,386,091 Total assets less current liabilities 6,123,650 3,940,554 Non-current liability Lease liabilities 873 850 Net assets 6,122,777 3,939,704 Capital and reserves Share capital 18,396 16,965 Reserves 6,104,381 3,922,739 Total equity 6,122,777 3,939,704